LPP (gene): Difference between revisions
m Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}}) |
m →Further reading: task using AWB |
||
Line 1: | Line 1: | ||
{{Infobox_gene}} | |||
{{ | '''Lipoma-preferred partner''' is a [[protein]] that in humans is encoded by the ''LPP'' [[gene]].<ref name="pmid8812423">{{cite journal |vauthors=Petit MM, Mols R, Schoenmakers EF, Mandahl N, Van de Ven WJ | title = LPP, the preferred fusion partner gene of HMGIC in lipomas, is a novel member of the LIM protein gene family | journal = Genomics | volume = 36 | issue = 1 | pages = 118–29 |date=Feb 1997 | pmid = 8812423 | pmc = | doi = 10.1006/geno.1996.0432 }}</ref><ref name="entrez">{{cite web | title = Entrez Gene: LPP LIM domain containing preferred translocation partner in lipoma| url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=4026| accessdate = }}</ref> | ||
| | |||
| | |||
| | |||
| | |||
| | |||
}} | |||
== Function == | |||
Lipoma-preferred partner is a subfamily of [[LIM domain]] proteins that are characterized by an [[N-terminus|N-terminal]] proline rich region and three [[C-terminus|C-terminal]] LIM domains. The encoded protein localizes to the cell periphery in focal adhesions and may be involved in cell-[[cell adhesion]] and [[motility|cell motility]]. This protein also shuttles through the nucleus and may function as a transcriptional co-activator. This gene is located at the junction of certain disease related chromosomal translocations which result in the expression of [[fusion protein]]s that may promote tumor growth.<ref name="entrez"/> | |||
==References== | ==References== | ||
{{reflist | {{reflist}} | ||
==Further reading== | ==Further reading== | ||
{{refbegin | 2}} | {{refbegin | 2}} | ||
*{{cite journal | author=Schoenmakers EF |title=Recurrent rearrangements in the high mobility group protein gene, HMGI-C, in benign mesenchymal tumours |journal=Nat. Genet. |volume=10 |issue= 4 |pages= 436–44 |year= 1995 |pmid= 7670494 |doi= 10.1038/ng0895-436 |name-list-format=vanc| author2=Wanschura S | author3=Mols R | display-authors=3 | last4=Bullerdiek | first4=Jörn | last5=Van Den Berghe | first5=Herman | last6=Van De Ven | first6=Wim J.M. }} | |||
*{{cite journal |vauthors=Petit MM, Swarts S, Bridge JA, Van de Ven WJ |title=Expression of reciprocal fusion transcripts of the HMGIC and LPP genes in parosteal lipoma |journal=Cancer Genet. Cytogenet. |volume=106 |issue= 1 |pages= 18–23 |year= 1998 |pmid= 9772904 |doi=10.1016/S0165-4608(98)00038-7 }} | |||
*{{cite journal | author=Schoenmakers EF | *{{cite journal | author=Petit MM |title=LPP, an Actin Cytoskeleton Protein Related to Zyxin, Harbors a Nuclear Export Signal and Transcriptional Activation Capacity |journal=Mol. Biol. Cell |volume=11 |issue= 1 |pages= 117–29 |year= 2000 |pmid= 10637295 |doi= 10.1091/mbc.11.1.117| pmc=14761 |name-list-format=vanc| author2=Fradelizi J | author3=Golsteyn RM | display-authors=3 | last4=Ayoubi | first4=TA | last5=Menichi | first5=B | last6=Louvard | first6=D | last7=Van De Ven | first7=WJ | last8=Friederich | first8=E }} | ||
*{{cite journal |vauthors=Rogalla P, Lemke I, Kazmierczak B, Bullerdiek J |title=An identical HMGIC-LPP fusion transcript is consistently expressed in pulmonary chondroid hamartomas with t(3;12)(q27-28;q14-15) |journal=Genes Chromosomes Cancer |volume=29 |issue= 4 |pages= 363–6 |year= 2001 |pmid= 11066083 |doi=10.1002/1098-2264(2000)9999:9999<1::AID-GCC1043>3.0.CO;2-N }} | |||
*{{cite journal | | *{{cite journal | author=Harrington JJ |title=Creation of genome-wide protein expression libraries using random activation of gene expression |journal=Nat. Biotechnol. |volume=19 |issue= 5 |pages= 440–5 |year= 2001 |pmid= 11329013 |doi= 10.1038/88107 |name-list-format=vanc| author2=Sherf B | author3=Rundlett S | display-authors=3 | last4=Jackson | first4=P. David | last5=Perry | first5=Rob | last6=Cain | first6=Scott | last7=Leventhal | first7=Christina | last8=Thornton | first8=Mark | last9=Ramachandran | first9=Rakesh }} | ||
*{{cite journal | author=Petit MM | *{{cite journal | author=Dahéron L |title=Human LPP gene is fused to MLL in a secondary acute leukemia with a t(3;11) (q28;q23) |journal=Genes Chromosomes Cancer |volume=31 |issue= 4 |pages= 382–9 |year= 2001 |pmid= 11433529 |doi= 10.1002/gcc.1157 |name-list-format=vanc| author2=Veinstein A | author3=Brizard F | display-authors=3 | last4=Drabkin | first4=Harry | last5=Lacotte | first5=Laurence | last6=Guilhot | first6=François | last7=Larsen | first7=Christian Jacques | last8=Brizard | first8=André | last9=Roche | first9=Joelle }} | ||
*{{cite journal |vauthors=Lemke I, Rogalla P, Bullerdiek J |title=A novel LPP fusion gene indicates the crucial role of truncated LPP proteins in lipomas and pulmonary chondroid hamartomas |journal=Cytogenet. Cell Genet. |volume=95 |issue= 3–4 |pages= 153–6 |year= 2002 |pmid= 12063392 |doi=10.1159/000059338 }} | |||
*{{cite journal | | *{{cite journal |vauthors=Petit MM, Meulemans SM, Van de Ven WJ |title=The focal adhesion and nuclear targeting capacity of the LIM-containing lipoma-preferred partner (LPP) protein |journal=J. Biol. Chem. |volume=278 |issue= 4 |pages= 2157–68 |year= 2003 |pmid= 12441356 |doi= 10.1074/jbc.M206106200 }} | ||
*{{cite journal | author= | *{{cite journal | author=Lemke I |title=Expression of the HMGA2-LPP fusion transcript in only 1 of 61 karyotypically normal pulmonary chondroid hamartomas |journal=Cancer Genet. Cytogenet. |volume=138 |issue= 2 |pages= 160–4 |year= 2003 |pmid= 12505264 |doi=10.1016/S0165-4608(02)00595-2 |name-list-format=vanc| author2=Rogalla P | author3=Grundmann F | display-authors=3 | last4=Kunze | first4=Wolf-Peter | last5=Haupt | first5=Rolf | last6=Bullerdiek | first6=Jörn }} | ||
*{{cite journal | author=Salomon AR |title=Profiling of tyrosine phosphorylation pathways in human cells using mass spectrometry |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=100 |issue= 2 |pages= 443–8 |year= 2003 |pmid= 12522270 |doi= 10.1073/pnas.2436191100 | pmc=141014 |name-list-format=vanc| author2=Ficarro SB | author3=Brill LM | display-authors=3 | last4=Brinker | first4=A | last5=Phung | first5=QT | last6=Ericson | first6=C | last7=Sauer | first7=K | last8=Brock | first8=A | last9=Horn | first9=DM }} | |||
*{{cite journal | author= | *{{cite journal |vauthors=Li B, Zhuang L, Reinhard M, Trueb B |title=The lipoma preferred partner LPP interacts with alpha-actinin |journal=J. Cell Sci. |volume=116 |issue= Pt 7 |pages= 1359–66 |year= 2003 |pmid= 12615977 |doi=10.1242/jcs.00309 }} | ||
*{{cite journal | author=Gorenne I |title=LPP, a LIM protein highly expressed in smooth muscle |journal=Am. J. Physiol., Cell Physiol. |volume=285 |issue= 3 |pages= C674–85 |year= 2003 |pmid= 12760907 |doi= 10.1152/ajpcell.00608.2002 |name-list-format=vanc| author2=Nakamoto RK | author3=Phelps CP | display-authors=3 | last4=Beckerle | first4=MC | last5=Somlyo | first5=AV | last6=Somlyo | first6=AP }} | |||
*{{cite journal | | *{{cite journal | author=Brill LM |title=Robust phosphoproteomic profiling of tyrosine phosphorylation sites from human T cells using immobilized metal affinity chromatography and tandem mass spectrometry |journal=Anal. Chem. |volume=76 |issue= 10 |pages= 2763–72 |year= 2004 |pmid= 15144186 |doi= 10.1021/ac035352d |name-list-format=vanc| author2=Salomon AR | author3=Ficarro SB | display-authors=3 | last4=Mukherji | first4=Mridul | last5=Stettler-Gill | first5=Michelle | last6=Peters | first6=Eric C. }} | ||
*{{cite journal | | *{{cite journal | author=Rush J |title=Immunoaffinity profiling of tyrosine phosphorylation in cancer cells |journal=Nat. Biotechnol. |volume=23 |issue= 1 |pages= 94–101 |year= 2005 |pmid= 15592455 |doi= 10.1038/nbt1046 |name-list-format=vanc| author2=Moritz A | author3=Lee KA | display-authors=3 | last4=Guo | first4=Ailan | last5=Goss | first5=Valerie L | last6=Spek | first6=Erik J | last7=Zhang | first7=Hui | last8=Zha | first8=Xiang-Ming | last9=Polakiewicz | first9=Roberto D }} | ||
*{{cite journal | author= | *{{cite journal | author=Petit MM |title=The tumor suppressor Scrib interacts with the zyxin-related protein LPP, which shuttles between cell adhesion sites and the nucleus |journal=BMC Cell Biol. |volume=6 |pages= 1 |year= 2006 |pmid= 15649318 |doi= 10.1186/1471-2121-6-1 | pmc=546208 |name-list-format=vanc| author2=Meulemans SM | author3=Alen P | display-authors=3 | last4=Ayoubi | first4=Torik AY | last5=Jansen | first5=Erik | last6=Van De Ven | first6=Wim JM }} | ||
*{{cite journal | author=Zhang Y |title=Time-resolved mass spectrometry of tyrosine phosphorylation sites in the epidermal growth factor receptor signaling network reveals dynamic modules |journal=Mol. Cell. Proteomics |volume=4 |issue= 9 |pages= 1240–50 |year= 2005 |pmid= 15951569 |doi= 10.1074/mcp.M500089-MCP200 |name-list-format=vanc| author2=Wolf-Yadlin A | author3=Ross PL | display-authors=3 | last4=Pappin | first4=DJ | last5=Rush | first5=J | last6=Lauffenburger | first6=DA | last7=White | first7=FM }} | |||
*{{cite journal | author= | *{{cite journal | author=Tao WA |title=Quantitative phosphoproteome analysis using a dendrimer conjugation chemistry and tandem mass spectrometry |journal=Nat. Methods |volume=2 |issue= 8 |pages= 591–8 |year= 2005 |pmid= 16094384 |doi= 10.1038/nmeth776 |name-list-format=vanc| author2=Wollscheid B | author3=O'Brien R | display-authors=3 | last4=Eng | first4=Jimmy K | last5=Li | first5=Xiao-jun | last6=Bodenmiller | first6=Bernd | last7=Watts | first7=Julian D | last8=Hood | first8=Leroy | last9=Aebersold | first9=Ruedi }} | ||
*{{cite journal |vauthors=von Ahsen I, Rogalla P, Bullerdiek J |title=Expression patterns of the LPP-HMGA2 fusion transcript in pulmonary chondroid hamartomas with t(3;12)(q27 approximately 28;q14 approximately 15) |journal=Cancer Genet. Cytogenet. |volume=163 |issue= 1 |pages= 68–70 |year= 2006 |pmid= 16271958 |doi= 10.1016/j.cancergencyto.2005.02.023 }} | |||
*{{cite journal | | *{{cite journal | author=Kubo T |title=Overexpression of HMGA2-LPP fusion transcripts promotes expression of the alpha 2 type XI collagen gene |journal=Biochem. Biophys. Res. Commun. |volume=340 |issue= 2 |pages= 476–81 |year= 2006 |pmid= 16375854 |doi= 10.1016/j.bbrc.2005.12.042 |name-list-format=vanc| author2=Matsui Y | author3=Goto T | display-authors=3 | last4=Yukata | first4=Kiminori | last5=Yasui | first5=Natsuo }} | ||
*{{cite journal | author= | |||
}} | |||
{{refend}} | {{refend}} | ||
{{ | {{NLM content}} | ||
{{ | |||
{{gene-3-stub}} |
Latest revision as of 20:13, 8 November 2017
VALUE_ERROR (nil) | |||||||
---|---|---|---|---|---|---|---|
Identifiers | |||||||
Aliases | |||||||
External IDs | GeneCards: [1] | ||||||
Orthologs | |||||||
Species | Human | Mouse | |||||
Entrez |
|
| |||||
Ensembl |
|
| |||||
UniProt |
|
| |||||
RefSeq (mRNA) |
|
| |||||
RefSeq (protein) |
|
| |||||
Location (UCSC) | n/a | n/a | |||||
PubMed search | n/a | n/a | |||||
Wikidata | |||||||
|
Lipoma-preferred partner is a protein that in humans is encoded by the LPP gene.[1][2]
Function
Lipoma-preferred partner is a subfamily of LIM domain proteins that are characterized by an N-terminal proline rich region and three C-terminal LIM domains. The encoded protein localizes to the cell periphery in focal adhesions and may be involved in cell-cell adhesion and cell motility. This protein also shuttles through the nucleus and may function as a transcriptional co-activator. This gene is located at the junction of certain disease related chromosomal translocations which result in the expression of fusion proteins that may promote tumor growth.[2]
References
- ↑ Petit MM, Mols R, Schoenmakers EF, Mandahl N, Van de Ven WJ (Feb 1997). "LPP, the preferred fusion partner gene of HMGIC in lipomas, is a novel member of the LIM protein gene family". Genomics. 36 (1): 118–29. doi:10.1006/geno.1996.0432. PMID 8812423.
- ↑ 2.0 2.1 "Entrez Gene: LPP LIM domain containing preferred translocation partner in lipoma".
Further reading
- Schoenmakers EF, Wanschura S, Mols R, et al. (1995). "Recurrent rearrangements in the high mobility group protein gene, HMGI-C, in benign mesenchymal tumours". Nat. Genet. 10 (4): 436–44. doi:10.1038/ng0895-436. PMID 7670494.
- Petit MM, Swarts S, Bridge JA, Van de Ven WJ (1998). "Expression of reciprocal fusion transcripts of the HMGIC and LPP genes in parosteal lipoma". Cancer Genet. Cytogenet. 106 (1): 18–23. doi:10.1016/S0165-4608(98)00038-7. PMID 9772904.
- Petit MM, Fradelizi J, Golsteyn RM, et al. (2000). "LPP, an Actin Cytoskeleton Protein Related to Zyxin, Harbors a Nuclear Export Signal and Transcriptional Activation Capacity". Mol. Biol. Cell. 11 (1): 117–29. doi:10.1091/mbc.11.1.117. PMC 14761. PMID 10637295.
- Rogalla P, Lemke I, Kazmierczak B, Bullerdiek J (2001). "An identical HMGIC-LPP fusion transcript is consistently expressed in pulmonary chondroid hamartomas with t(3;12)(q27-28;q14-15)". Genes Chromosomes Cancer. 29 (4): 363–6. doi:10.1002/1098-2264(2000)9999:9999<1::AID-GCC1043>3.0.CO;2-N. PMID 11066083.
- Harrington JJ, Sherf B, Rundlett S, et al. (2001). "Creation of genome-wide protein expression libraries using random activation of gene expression". Nat. Biotechnol. 19 (5): 440–5. doi:10.1038/88107. PMID 11329013.
- Dahéron L, Veinstein A, Brizard F, et al. (2001). "Human LPP gene is fused to MLL in a secondary acute leukemia with a t(3;11) (q28;q23)". Genes Chromosomes Cancer. 31 (4): 382–9. doi:10.1002/gcc.1157. PMID 11433529.
- Lemke I, Rogalla P, Bullerdiek J (2002). "A novel LPP fusion gene indicates the crucial role of truncated LPP proteins in lipomas and pulmonary chondroid hamartomas". Cytogenet. Cell Genet. 95 (3–4): 153–6. doi:10.1159/000059338. PMID 12063392.
- Petit MM, Meulemans SM, Van de Ven WJ (2003). "The focal adhesion and nuclear targeting capacity of the LIM-containing lipoma-preferred partner (LPP) protein". J. Biol. Chem. 278 (4): 2157–68. doi:10.1074/jbc.M206106200. PMID 12441356.
- Lemke I, Rogalla P, Grundmann F, et al. (2003). "Expression of the HMGA2-LPP fusion transcript in only 1 of 61 karyotypically normal pulmonary chondroid hamartomas". Cancer Genet. Cytogenet. 138 (2): 160–4. doi:10.1016/S0165-4608(02)00595-2. PMID 12505264.
- Salomon AR, Ficarro SB, Brill LM, et al. (2003). "Profiling of tyrosine phosphorylation pathways in human cells using mass spectrometry". Proc. Natl. Acad. Sci. U.S.A. 100 (2): 443–8. doi:10.1073/pnas.2436191100. PMC 141014. PMID 12522270.
- Li B, Zhuang L, Reinhard M, Trueb B (2003). "The lipoma preferred partner LPP interacts with alpha-actinin". J. Cell Sci. 116 (Pt 7): 1359–66. doi:10.1242/jcs.00309. PMID 12615977.
- Gorenne I, Nakamoto RK, Phelps CP, et al. (2003). "LPP, a LIM protein highly expressed in smooth muscle". Am. J. Physiol., Cell Physiol. 285 (3): C674–85. doi:10.1152/ajpcell.00608.2002. PMID 12760907.
- Brill LM, Salomon AR, Ficarro SB, et al. (2004). "Robust phosphoproteomic profiling of tyrosine phosphorylation sites from human T cells using immobilized metal affinity chromatography and tandem mass spectrometry". Anal. Chem. 76 (10): 2763–72. doi:10.1021/ac035352d. PMID 15144186.
- Rush J, Moritz A, Lee KA, et al. (2005). "Immunoaffinity profiling of tyrosine phosphorylation in cancer cells". Nat. Biotechnol. 23 (1): 94–101. doi:10.1038/nbt1046. PMID 15592455.
- Petit MM, Meulemans SM, Alen P, et al. (2006). "The tumor suppressor Scrib interacts with the zyxin-related protein LPP, which shuttles between cell adhesion sites and the nucleus". BMC Cell Biol. 6: 1. doi:10.1186/1471-2121-6-1. PMC 546208. PMID 15649318.
- Zhang Y, Wolf-Yadlin A, Ross PL, et al. (2005). "Time-resolved mass spectrometry of tyrosine phosphorylation sites in the epidermal growth factor receptor signaling network reveals dynamic modules". Mol. Cell. Proteomics. 4 (9): 1240–50. doi:10.1074/mcp.M500089-MCP200. PMID 15951569.
- Tao WA, Wollscheid B, O'Brien R, et al. (2005). "Quantitative phosphoproteome analysis using a dendrimer conjugation chemistry and tandem mass spectrometry". Nat. Methods. 2 (8): 591–8. doi:10.1038/nmeth776. PMID 16094384.
- von Ahsen I, Rogalla P, Bullerdiek J (2006). "Expression patterns of the LPP-HMGA2 fusion transcript in pulmonary chondroid hamartomas with t(3;12)(q27 approximately 28;q14 approximately 15)". Cancer Genet. Cytogenet. 163 (1): 68–70. doi:10.1016/j.cancergencyto.2005.02.023. PMID 16271958.
- Kubo T, Matsui Y, Goto T, et al. (2006). "Overexpression of HMGA2-LPP fusion transcripts promotes expression of the alpha 2 type XI collagen gene". Biochem. Biophys. Res. Commun. 340 (2): 476–81. doi:10.1016/j.bbrc.2005.12.042. PMID 16375854.
This article incorporates text from the United States National Library of Medicine, which is in the public domain.
This article on a gene on human chromosome 3 is a stub. You can help Wikipedia by expanding it. |